[Effector proteins of Clamidia].
The review summarizes the recent published data on molecular mechanisms of Chlamidiae - host cell interaction, first of all on chlamydial effector proteins. Such proteins as well as III transport system proteins that transfer many effector proteins into host cytoplasm are attractive targets for drug therapy of chlamydial infections. The majority of the data concerns two species, Chlamydia trachomatis and Chlamydophila pneumoniae. C. trachomatis protein TARP, which is presynthesized in elementary bodies, plays an essential role in the initial stages of the infection. Patogen proteins participating in the next stage, that is the intracellular inclusion traffic to the centrosome, are CT229 of C. trachomatis and Cpn0585 of C. pneumoniae, which interact with cellular Rab GTPases. In C. trachomatis, IncA protein plays a key role in chlamydial inclusions fusion, CT847 modulates life cycle of the host cell, LDA3 is essential in acquisition of nutrients. CPAF protease and inclusion membrane proteins IncG and CADD participate in suppression of apoptosis of infected cells. The proteases CPAF and CT441, as well as deubiquitinating ChlaDub1 protein, contribute to avoiding the immune response.
Kariagina
A S
AS
Alekseevskiĭ
A V
AV
Spirin
S A
SA
Zigangirova
N A
NA
Gintsburg
A L
AL
D000818:Animals; D001426:Bacterial Proteins / Q000235:genetics / Q000378:metabolism*; D002690:Chlamydia Infections / Q000235:genetics / Q000378:metabolism* / Q000382:microbiology; D002692:Chlamydia trachomatis / Q000235:genetics / Q000378:metabolism*; D023521:Chlamydophila Infections / Q000235:genetics / Q000378:metabolism* / Q000382:microbiology; D016993:Chlamydophila pneumoniae / Q000235:genetics / Q000378:metabolism*; D054884:Host-Pathogen Interactions; D006801:Humans
D001426:Bacterial Proteins